Organic Letters
Letter
its enantiomer was examined in the same way to give 13 and
Ministry of Education, Culture, Sports, Science and Technol-
ogy, Japan.
14, and the configuration of 13 was established as (2R,3R).
Then, 11, 13, and the reduction product of poecillastrin C were
hydrolyzed and subjected to Marfey’s analysis, which
demonstrated that the hydrolysate of 13 and the reduction
product of poecillastrin C were identical (Figure 1, SI).
Therefore, the structure of poecillastrin C was reassigned as 2.
REFERENCES
■
(1) Cantrell, C. L.; Gustafson, K. R.; Cecere, M. R.; Pannell, L. K.;
Boyd, M. R. J. Am. Chem. Soc. 2000, 122, 8825−8829.
2) Rashid, M. A.; Cantrell, C. L.; Gustafson, K. R.; Boyd, M. R. J.
(
Nat. Prod. 2001, 64, 1341−1344.
3) Rashid, M. A.; Gustafson, K. R.; Boyd, M. R. Tetrahedron Lett.
001, 42, 1623−1626.
4) Chevallier, C.; Laprevote, O.; Bignon, J.; Debitus, C.; Guenard,
D.; Sevenet, T. Nat. Prod. Res. 2004, 18, 479−484.
5) Rashid, M. A.; Gustafson, K. R.; Crouch, R. C.; Groweiss, A.;
Pannell, L. K.; Van, Q. N.; Boyd, M. R. Org. Lett. 2002, 4, 3293−3296.
6) Takada, K.; Choi, B. W.; Rashid, M. A.; Gamble, W. R.;
(
2
(
(
(
Cardellina, J. H., II; Van, Q. N.; Lloyd, J. R.; McMahon, J. B.;
Gustafson, K. R. J. Nat. Prod. 2007, 70, 428−431.
(7) Takemoto, D.; Takekawa, Y.; van Soest, R. W. M.; Fusetani, N.;
Matsunaga, S. Biosci., Biotechnol., Biochem. 2007, 71, 2697−2700.
8) (a) Plaza, A.; Baker, H. L.; Bewley, C. A. J. Nat. Prod. 2008, 71,
73−477. (b) Correction: Plaza, A.; Baker, H. L.; Bewley, C. A. J. Nat.
Prod. 2009, 72, 324−324.
9) Bowman, E. J.; Gustafson, K. R.; Bowman, B. J.; Boyd, M. R. J.
Biol. Chem. 2003, 278, 44147−44152.
10) Attempts were made to synthesize mirabalin without the
information on the absolute configuration: (a) Echeverria, P.-G.;
Prevost, S.; Cornil, J.; Ferard, C.; Reymond, S.; Guerinot, A.; Cossy, J.;
(
4
Figure 1. LC−MS chromatograms of Marfey’s derivatives: (a) acid
hydrolysate of 11; (b) acid hydrolysate of 13; (c) acid hydrolysate of
the reduction product of poecillastrin C.
(
(
The same set of experiments run with authentic samples of
poecillastrins B, D, and 73-deoxychondropsin A liberated 4,
demonstrating that the mode of ester formation in these
compounds had to be revised (SI).
́
́
́
Ratovelomanana-Vidal, V.; Phansavath, P. Org. Lett. 2014, 16, 2390−
2393. (b) Cornil, J.; Echeverria, P.-G.; Reymond, S.; Phansavath, P.;
Ratovelomanana-Vidal, V.; Guerinot, A.; Cossy, J. Org. Lett. 2016, 18,
4534−4537.
A combination of microscale reduction, hydrolysis, and
derivatization reactions was performed on four different
poecillastrin and chondropsin macrolides, and the resulting
products were compared with appropriate synthetic standards.
The natural products all provided derivatives of the OHAsp
residue that are only consistent with macrolactonization
occurring via the side chain carbonyl and not the α-amino
acid carbonyl. In this work, we showed that the planar
structures of the chondropsin/poecillastrin class of metabolites
need to be revised, setting the stage for further stereochemical
assignment of this class of bioactive compounds.
(11) Hirosawa, S.; Takahashi, Y.; Hashizume, H.; Miyake, T.;
Akamatsu, Y. J. Antibiot. 2014, 67, 265−268.
(12) Marfey, P. Carlsberg Res. Commun. 1984, 49, 591−596.
(13) Reddy, K. L.; Sharpless, K. B. J. Am. Chem. Soc. 1998, 120,
1
(
207−1217.
14) (a) Esgulian, M.; Belot, V.; Guillot, R.; Deloisy, S.; Aitken, D. J.
Org. Biomol. Chem. 2017, 15, 1453−1462. (b) Gutierrez, M. L.;
Garrabou, X.; Agosta, E.; Servi, S.; Parella, T.; Joglar, J.; Clapes, P.
Chem. - Eur. J. 2008, 14, 4647−4656.
(15) Ohtani, I.; Kusumi, T.; Kashman, Y.; Kakisawa, H. J. Am. Chem.
Soc. 1991, 113, 4092−4096.
ASSOCIATED CONTENT
Supporting Information
■
*
S
Description of experimental procedure, LC−MS chro-
matograms, and NMR spectra (PDF)
AUTHOR INFORMATION
■
*
*
ORCID
Notes
The authors declare no competing financial interest.
ACKNOWLEDGMENTS
This work was partly supported by JSPS KAKENHI Grant Nos.
5252037, 16H04980, 17J08775, and 17H06403 from The
■
2
C
Org. Lett. XXXX, XXX, XXX−XXX